New Rx Treats Most Common Inherited Bleeding Disorder
Patients with von Willebrand disease (VWD) lack a protein that's essential for healthy blood clotting. But a newly approved medication could help with that.
FDA Approves New von Willebrand Rx
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD).
Blood Type Vs. Heart Surgery Risk
Patients with a certain blood type may have a naturally lower risk of dying after heart surgery. Two added blood proteins mean that patients with AB blood are 20 percent are more likely to survive.
Clues to Blood Clotting
Evolutionary clues have led scientists to a discovery of how a key clotting protein assembles. This could aid in better understanding, and possibly treatments for common bleeding disorders.